These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9751750)

  • 1. Expression and crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and an immunodominant peptide of human myelin basic protein.
    Gauthier L; Smith KJ; Pyrdol J; Kalandadze A; Strominger JL; Wiley DC; Wucherpfennig KW
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11828-33. PubMed ID: 9751750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
    Krogsgaard M; Wucherpfennig KW; Cannella B; Hansen BE; Svejgaard A; Pyrdol J; Ditzel H; Raine C; Engberg J; Fugger L
    J Exp Med; 2000 Apr; 191(8):1395-412. PubMed ID: 10770805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.
    Wucherpfennig KW; Sette A; Southwood S; Oseroff C; Matsui M; Strominger JL; Hafler DA
    J Exp Med; 1994 Jan; 179(1):279-90. PubMed ID: 7505801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2.
    Chang JW; Mechling DE; Bächinger HP; Burrows GG
    J Biol Chem; 2001 Jun; 276(26):24170-6. PubMed ID: 11319230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of recombinant HLA-DR2 molecules. Replacement of the hydrophobic transmembrane region by a leucine zipper dimerization motif allows the assembly and secretion of soluble DR alpha beta heterodimers.
    Kalandadze A; Galleno M; Foncerrada L; Strominger JL; Wucherpfennig KW
    J Biol Chem; 1996 Aug; 271(33):20156-62. PubMed ID: 8702739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
    Li Y; Li H; Martin R; Mariuzza RA
    J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restricted TCR Valpha gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis.
    Zang YC; Kozovska M; Aebischer I; Li S; Boehme S; Crowe P; Rivera VM; Zhang JZ
    Int Immunol; 1998 Jul; 10(7):991-8. PubMed ID: 9701037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells.
    Vergelli M; Kalbus M; Rojo SC; Hemmer B; Kalbacher H; Tranquill L; Beck H; McFarland HF; De Mars R; Long EO; Martin R
    J Neuroimmunol; 1997 Aug; 77(2):195-203. PubMed ID: 9258250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein.
    Smith KJ; Pyrdol J; Gauthier L; Wiley DC; Wucherpfennig KW
    J Exp Med; 1998 Oct; 188(8):1511-20. PubMed ID: 9782128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.
    Wucherpfennig KW; Hafler DA; Strominger JL
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8896-900. PubMed ID: 7568039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH dependent binding of high and low affinity myelin basic protein peptides to purified HLA-DR2.
    Mukku PV; Passmore D; Phan D; Nag B
    Mol Immunol; 1995 Jun; 32(8):555-64. PubMed ID: 7541890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of T-cell receptor binding by bivalent HLA-DR. Peptide complexes that activate antigen-specific human T-cells.
    Appel H; Gauthier L; Pyrdol J; Wucherpfennig KW
    J Biol Chem; 2000 Jan; 275(1):312-21. PubMed ID: 10617620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.
    Wucherpfennig KW; Catz I; Hausmann S; Strominger JL; Steinman L; Warren KG
    J Clin Invest; 1997 Sep; 100(5):1114-22. PubMed ID: 9276728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-zeta chimeric receptor.
    Moisini I; Nguyen P; Fugger L; Geiger TL
    J Immunol; 2008 Mar; 180(5):3601-11. PubMed ID: 18292588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic peptides that inhibit binding of the myelin basic protein 85-99 epitope to multiple sclerosis-associated HLA-DR2 molecules and MBP-specific T-cell responses.
    Fridkis-Hareli M; Stern JN; Fugger L; Strominger JL
    Hum Immunol; 2001 Aug; 62(8):753-63. PubMed ID: 11476898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions.
    Godkin AJ; Smith KJ; Willis A; Tejada-Simon MV; Zhang J; Elliott T; Hill AV
    J Immunol; 2001 Jun; 166(11):6720-7. PubMed ID: 11359828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anergy induction by dimeric TCR ligands.
    Appel H; Seth NP; Gauthier L; Wucherpfennig KW
    J Immunol; 2001 Apr; 166(8):5279-85. PubMed ID: 11290814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionally active recombinant alpha and beta chain-peptide complexes of human major histocompatibility class II molecules.
    Nag B; Arimilli S; Mukku PV; Astafieva I
    J Biol Chem; 1996 Apr; 271(17):10413-8. PubMed ID: 8626615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.
    Pette M; Fujita K; Wilkinson D; Altmann DM; Trowsdale J; Giegerich G; Hinkkanen A; Epplen JT; Kappos L; Wekerle H
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7968-72. PubMed ID: 1700423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.